LLLi Li

Li Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Li Li has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Fengchun Yang

    Institute of Medical Information, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

    2 shared publications
  • Fenglian Shi

    Department of Obstetrics and Gynecology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China

    2 shared publications
  • Jing Guo

    Department of Obstetrics and Gynecology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China

    2 shared publications
  • Qing Hua

    Department of Obstetrics and Gynecology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China

    2 shared publications
  • Qing Hua

    Department of Obstetrics and Gynecology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China

    2 shared publications
  • Xiaoyan You

    Department of Obstetrics and Gynecology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China

    2 shared publications

Latest Publications

  • SLC6A8-centered placental molecular signature predicts fetal growth restriction via machine learning and single-cell analysis

    by Qing Hua, Xiaoyan You, Xujing Yan, Yanping Xin, Dongmei Zhang, Xiaona Tian, Li Li

  • Open Access

    Predictive Models Using Machine Learning to Identify Fetal Growth Restriction in Patients With Preeclampsia: Development and Evaluation Study

    by Qing Hua, Fengchun Yang, Yadan Zhou, Fenglian Shi, Xiaoyan You, Jing Guo, Li Li

    Background: Fetal growth restriction (FGR) is a common complication of preeclampsia. FGR in patients with preeclampsia increases the risk of neonatal-perinatal mortality and morbidity. However, previous prediction methods for FGR are class-biased or clinically unexplainable, which makes it difficult to apply to clinical practice, leading to a relative delay in intervention and a lack of effective treatments. Objective: The study aims to develop an auxiliary diagnostic model based on machine learning (ML) to predict the occurrence of FGR in patients with preeclampsia. Methods: This study used a retrospective case-control approach to analyze 38 features, including the basic medical history and peripheral blood laboratory test results of pregnant patients with preeclampsia, either complicated or not complicated by FGR. ML models were constructed to evaluate the predictive value of maternal parameter changes on preeclampsia combined with FGR. Multiple algorithms were tested, including logistic regression, light gradient boosting, random forest (RF), extreme gradient boosting, multilayer perceptron, naive Bayes, and support vector machine. The model performance was identified by the area under the curve (AUC) and other evaluation indexes. The Shapley additive explanations (SHAP) method was adopted to rank the feature importance and explain the final model for clinical application. Results: The RF model performed best in discriminative ability among the 7 ML models. After reducing features according to importance rank, an explainable final RF model was established with 9 features, including urinary protein quantification, gestational week of delivery, umbilical artery systolic-to-diastolic ratio, amniotic fluid index, triglyceride, D-dimer, weight, height, and maximum systolic pressure. The model could accurately predict FGR for 513 patients with preeclampsia (149 with FGR and 364 without FGR) in the training and testing dataset (AUC 0.83, SD 0.03) using 5-fold cross-validation, which was closely validated for 103 patients with preeclampsia (n=45 with FGR and n=58 without FGR) in an external dataset (AUC 0.82, SD 0.048). On the whole, urinary protein quantification, umbilical artery systolic-to-diastolic ratio, and gestational week of delivery exhibited the highest contributions to the model performance (c=0.45, 0.34, and 0.33) based on SHAP analysis. For specific individual patients, SHAP results reveal the protective and risk factors to develop FGR for interpreting the model’s clinical significance. Finally, the model has been translated into a convenient web page tool to facilitate its use in clinical settings. Conclusions: The study successfully developed a model that accurately predicts FGR development in patients with preeclampsia. The SHAP method captures highly relevant risk factors for model interpretation, alleviating concerns about the “black box” problem of ML techniques.


  • Open Access

    Predictive Models Using Machine Learning to Identify Fetal Growth Restriction in Patients With Preeclampsia: Development and Evaluation Study (Preprint)

    by Qing Hua, Fengchun Yang, Yadan Zhou, Fenglian Shi, Xiaoyan You, Jing Guo, Li Li

    BACKGROUND Fetal growth restriction (FGR) is a common complication of preeclampsia. FGR in patients with preeclampsia increases the risk of neonatal-perinatal mortality and morbidity. However, previous prediction methods for FGR are class-biased or clinically unexplainable, which makes it difficult to apply to clinical practice, leading to a relative delay in intervention and a lack of effective treatments. OBJECTIVE The study aims to develop an auxiliary diagnostic model based on machine learning (ML) to predict the occurrence of FGR in patients with preeclampsia. METHODS This study used a retrospective case-control approach to analyze 38 features, including the basic medical history and peripheral blood laboratory test results of pregnant patients with preeclampsia, either complicated or not complicated by FGR. ML models were constructed to evaluate the predictive value of maternal parameter changes on preeclampsia combined with FGR. Multiple algorithms were tested, including logistic regression, light gradient boosting, random forest (RF), extreme gradient boosting, multilayer perceptron, naive Bayes, and support vector machine. The model performance was identified by the area under the curve (AUC) and other evaluation indexes. The Shapley additive explanations (SHAP) method was adopted to rank the feature importance and explain the final model for clinical application. RESULTS The RF model performed best in discriminative ability among the 7 ML models. After reducing features according to importance rank, an explainable final RF model was established with 9 features, including urinary protein quantification, gestational week of delivery, umbilical artery systolic-to-diastolic ratio, amniotic fluid index, triglyceride, D-dimer, weight, height, and maximum systolic pressure. The model could accurately predict FGR for 513 patients with preeclampsia (149 with FGR and 364 without FGR) in the training and testing dataset (AUC 0.83, SD 0.03) using 5-fold cross-validation, which was closely validated for 103 patients with preeclampsia (n=45 with FGR and n=58 without FGR) in an external dataset (AUC 0.82, SD 0.048). On the whole, urinary protein quantification, umbilical artery systolic-to-diastolic ratio, and gestational week of delivery exhibited the highest contributions to the model performance (c=0.45, 0.34, and 0.33) based on SHAP analysis. For specific individual patients, SHAP results reveal the protective and risk factors to develop FGR for interpreting the model’s clinical significance. Finally, the model has been translated into a convenient web page tool to facilitate its use in clinical settings. CONCLUSIONS The study successfully developed a model that accurately predicts FGR development in patients with preeclampsia. The SHAP method captures highly relevant risk factors for model interpretation, alleviating concerns about the “black box” problem of ML techniques.

  • Open Access

    Single-cell RNA sequencing reveals association of aberrant placental trophoblasts and FN1 reduction in late-onset fetal growth restriction

    by Qing Hua, Zhe Li, Yadan Zhou, Yali Wang, Yangyang Yu, Lei Sun, Jianping Ye, Li Li